Actinogen Medical (ASX:ACW)

Actinogen Medical is an ASX-listed biotechnology company developing innovative treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes.

Latest Article

ACW Starts Phase II Clinical Trials: Major Milestone Set to Unlock Value Uplift?

ACW Starts Phase II Clinical Trials: Major Milestone Set to Unlock Value Uplift?

There are currently an estimated 50 million suffers of Alzheimer’s disease (AD) globally, the highest rate in history. The consequent costs on healthcare providers are enormous and growing.

READ ARTICLE

Related Actinogen Medical (ASX:ACW) articles

Top Trending